Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A proof of concept trial of Epinephrine Sublingual Soluble Film for the treatment of anaphylaxis

Trial Profile

A proof of concept trial of Epinephrine Sublingual Soluble Film for the treatment of anaphylaxis

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 26 Mar 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Epinephrine (Primary)
  • Indications Anaphylaxis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Aquestive Therapeutics
  • Most Recent Events

    • 25 Mar 2021 According to an Aquestive Therapeutics media release, the company plans on meeting with the FDA in the second half of 2021 to review these results and discuss next steps in the development of AQST-108.
    • 25 Mar 2021 According to an Aquestive Therapeutics media release, data from this trial will be presented in R&D event.
    • 25 Mar 2021 Results published in an Aquestive Therapeutics media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top